CG Oncology stock (CGON) jumps 29% on faster Phase 3 timeline — what to watch next week

CG Oncology shares jumped 29.3% to close at $54.20 on Friday, hitting a session high of $57.40 amid increased interest ahead of a critical bladder-cancer readout. Trading volume came in around 7.0 million shares.

12 January 2026

Company hubNASDAQ:CGON

CG Oncology (CGON) Stock News & Analysis

Follow the latest CG Oncology (CGON) company news, earnings coverage and investor analysis from TechStock².

Save this hub to your TS2 Signalbook account.

Latest update: 12 January 2026
Articles in this hub: 3
Last 30 days: 0

What investors are watching

Earnings, guidance and financial performance
Valuation, trading activity and market sentiment
Strategy, catalysts and company-specific risks

Read latest coverage Prefer TechStock² in Google

CG Oncology stock (CGON) jumps 29% on faster PIVOT-006 Phase 3 readout — what to watch next

CG Oncology shares jumped 29.26% on Friday, finishing at $54.20, setting a strong tone for Monday’s open. The boost came after the company announced it now anticipates Phase 3 PIVOT-006 topline results in the first half of 2026.

11 January 2026

NASDAQ:CGON·Stock Market

CG Oncology stock jumps 29% on faster Phase 3 PIVOT-006 data clock — what to watch next

CG Oncology Inc shares surged nearly 29% on Friday, closing at $54.20 after hitting a session high of $57.36. The stock gained $12.25 during the day on volume of about 7.0 million shares.

11 January 2026

Biotechnology·NASDAQ:CGON·Stock Market